研究单位:[1]Huazhong University of Science and Technology[2]Tongji Hospital,Huazhong University of Science and Technology[3]Shiyan Taihe Hospital
研究目的:
This study is meant to evaluate the safety and efficacy of rAAV2-ND4 treatment for Leber hereditary optic neuropathy with the G11778A mutation in mitochondrial DNA.